mesalamine has been researched along with Behcet Syndrome in 18 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Behcet Syndrome: Rare chronic inflammatory disease involving the small blood vessels. It is of unknown etiology and characterized by mucocutaneous ulceration in the mouth and genital region and uveitis with hypopyon. The neuro-ocular form may cause blindness and death. SYNOVITIS; THROMBOPHLEBITIS; gastrointestinal ulcerations; RETINAL VASCULITIS; and OPTIC ATROPHY may occur as well.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Furthermore, the ulcer has since maintained the scar stage despite successfully weaning the patient from PSL." | 1.48 | Effects of the Concomitant Use of Low-dose Clarithromycin with an Anti-TNFα Antibody in a Patient with Intestinal Behçet Disease. ( Hirayama, T; Honda, A; Ikegami, T; Iwamoto, J; Konishi, N; Matsuzaki, Y; Monma, T; Murakami, M; Ueda, H; Yara, S, 2018) |
| "During the follow-up period, cumulative recurrence rates for intestinal BD were 24." | 1.36 | Response rates to medical treatments and long-term clinical outcomes of nonsurgical patients with intestinal Behçet disease. ( Cheon, JH; Chung, MJ; Kim, NK; Kim, SU; Kim, TI; Kim, WH; Park, JJ, 2010) |
| "Intestinal Behcet's disease in a 19-year-old girl was diagnosed because of the history of recurrent oral aphthous ulcers and typical endoscopic findings of esophageal and ileal ulcers." | 1.31 | The beneficial effect of mesalazine on esophageal ulcers in intestinal Behcet's disease. ( Araki, Y; Chijiiwa, Y; Harada, N; Koubokawa, M; Nawata, H; Ochiai, T; Sonta, T; Tamura, Y, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.56) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 12 (66.67) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, HJ | 1 |
| Kim, KT | 1 |
| Lee, SG | 1 |
| Kim, Y | 1 |
| Iwamoto, J | 1 |
| Murakami, M | 1 |
| Konishi, N | 1 |
| Monma, T | 1 |
| Ueda, H | 1 |
| Yara, S | 1 |
| Hirayama, T | 1 |
| Ikegami, T | 1 |
| Honda, A | 1 |
| Matsuzaki, Y | 1 |
| Park, YE | 1 |
| Cheon, JH | 3 |
| Zhu, Z | 1 |
| Shu, X | 1 |
| Long, S | 1 |
| Jiang, X | 1 |
| Lu, N | 1 |
| Zhu, X | 1 |
| Liao, W | 1 |
| Awaji, K | 1 |
| Inokuchi, R | 1 |
| Maehara, H | 1 |
| Moriyama, M | 1 |
| Ohmae, T | 1 |
| Okamoto, M | 1 |
| Suyama, Y | 1 |
| Tominaga, K | 1 |
| Kamimura, K | 1 |
| Takahashi, K | 1 |
| Yokoyama, J | 1 |
| Terai, S | 1 |
| Sato, S | 1 |
| Yashiro, M | 1 |
| Matsuoka, N | 1 |
| Kawana, S | 1 |
| Asano, T | 1 |
| Kobayashi, H | 1 |
| Tasaki, K | 1 |
| Watanabe, H | 1 |
| Hashimoto, Y | 2 |
| Migita, K | 1 |
| Kinoshita, H | 1 |
| Nishioka, H | 1 |
| Ikeda, A | 1 |
| Ikoma, K | 1 |
| Sameshima, Y | 1 |
| Ohi, H | 1 |
| Tatsuno, M | 1 |
| Kouyama, J | 1 |
| Kawamoto, C | 1 |
| Mitsui, T | 1 |
| Tamura, Y | 2 |
| Nishio, M | 1 |
| Ogashiwa, T | 1 |
| Saigusa, Y | 1 |
| Maeda, S | 1 |
| Kimura, H | 1 |
| Kunisaki, R | 1 |
| Koike, K | 1 |
| Hu, YC | 1 |
| Yang, YH | 1 |
| Lin, YT | 1 |
| Wang, LC | 1 |
| Yu, HH | 1 |
| Lee, JH | 1 |
| Chiang, BL | 1 |
| Fan, S | 1 |
| Li, Y | 1 |
| Lopalco, G | 1 |
| Rigante, D | 1 |
| Venerito, V | 1 |
| Fabiani, C | 1 |
| Franceschini, R | 1 |
| Barone, M | 1 |
| Lapadula, G | 1 |
| Galeazzi, M | 1 |
| Frediani, B | 1 |
| Iannone, F | 1 |
| Cantarini, L | 1 |
| Chung, MJ | 1 |
| Kim, SU | 1 |
| Park, JJ | 1 |
| Kim, TI | 3 |
| Kim, NK | 1 |
| Kim, WH | 3 |
| Jung, YS | 1 |
| Park, SJ | 1 |
| Hong, SP | 1 |
| Ono, M | 1 |
| Murakami, K | 1 |
| Oda, M | 1 |
| Miyajima, H | 1 |
| Watanabe, K | 1 |
| Sato, R | 1 |
| Nasu, M | 1 |
| Kashima, K | 1 |
| Choi, CH | 1 |
| Kim, BC | 1 |
| Shin, SJ | 1 |
| Lee, SK | 1 |
| Kim, HS | 1 |
| Kitauchi, S | 1 |
| Ohata, H | 1 |
| Kuroda, R | 1 |
| Hirose, M | 1 |
| Sakaguchi, A | 1 |
| Nishi, S | 1 |
| Nishioka, S | 1 |
| Sonta, T | 1 |
| Araki, Y | 1 |
| Koubokawa, M | 1 |
| Ochiai, T | 1 |
| Harada, N | 1 |
| Chijiiwa, Y | 1 |
| Nawata, H | 1 |
| Ranzi, T | 1 |
| Campanini, M | 1 |
| Bianchi, PA | 1 |
3 reviews available for mesalamine and Behcet Syndrome
| Article | Year |
|---|---|
Updated treatment strategies for intestinal Behçet's disease.
Topics: Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Behcet Syndrome; Gastrointestinal Agents; Human | 2018 |
Update on the Medical Management of Gastrointestinal Behçet's Disease.
Topics: Adrenal Cortex Hormones; Animals; Behcet Syndrome; Gastrointestinal Tract; Humans; Immunologic Facto | 2017 |
[A case of simple ulcer with ulcerative colitis].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Behcet Syndrome; Cecal Diseases; Colit | 2005 |
15 other studies available for mesalamine and Behcet Syndrome
| Article | Year |
|---|---|
Successful combination therapy using adalimumab and 5-aminosalicylic acid for a resistant case of intestinal Behçet's disease.
Topics: Adalimumab; Adult; Behcet Syndrome; Female; Humans; Infliximab; Mesalamine; Treatment Outcome; Young | 2020 |
Effects of the Concomitant Use of Low-dose Clarithromycin with an Anti-TNFα Antibody in a Patient with Intestinal Behçet Disease.
Topics: Adalimumab; Aged; Anti-Inflammatory Agents; Behcet Syndrome; Cecal Diseases; Clarithromycin; Drug Th | 2018 |
Ulcerative colitis followed by the development of typical intestinal Behçet disease: A case report.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Behcet Syndrome; Colitis, Ulce | 2018 |
Gastrointestinal Behçet's disease: periodic fever, multiple ulcers and trisomy 8 in elderly man.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Behcet Syndrome; Capsule Endoscopy; Chromosomes, Huma | 2018 |
A case of Behçet's disease with various gastrointestinal findings.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Behcet Syndrome; Colitis, U | 2018 |
Behçet disease associated with gastrointestinal amyloidosis manifested as hematochezia: A case report.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Behcet Syndrome; Colchicine; Colon; Colonic Diseases; Gastr | 2018 |
Remission induction, maintenance, and endoscopic outcome with oral 5-aminosalicylic acid in intestinal Behçet's disease.
Topics: Adolescent; Adult; Aged; Behcet Syndrome; Endoscopy; Female; Humans; Intestinal Diseases; Maintenanc | 2019 |
Clinical manifestations and anti-TNF alpha therapy of juvenile Behçet's disease in Taiwan.
Topics: Adalimumab; Adolescent; Antirheumatic Agents; Behcet Syndrome; Child; Colchicine; Drug Therapy, Comb | 2019 |
[Advances in diagnosis and treatment of intestinal Behcet's disease].
Topics: Behcet Syndrome; Colonoscopy; Humans; Immunosuppressive Agents; Intestinal Diseases; Mesalamine | 2015 |
Response rates to medical treatments and long-term clinical outcomes of nonsurgical patients with intestinal Behçet disease.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathiopr | 2010 |
Clinical course of intestinal Behcet's disease during the first five years.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Behcet Syndrome; Disease Pr | 2013 |
Anti-Saccharomyces cerevisiae antibody in intestinal Behçet's disease patients: relation to clinical course.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Fungal; Behcet Syndrom | 2006 |
[Follow-up observation of intestinal Behçet disease treated with salazosulfapyridine and mesalazine for 8 years and 9 months].
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Behcet Syndrome; Follow-Up Studie | 1998 |
The beneficial effect of mesalazine on esophageal ulcers in intestinal Behcet's disease.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Behcet Syndrome; Esophagea | 2000 |
Successful treatment of genital and oral ulceration in Behçet's disease with topical 5-aminosalicylic acid (5-ASA)
Topics: Administration, Topical; Adult; Aminosalicylic Acids; Behcet Syndrome; Female; Humans; Mesalamine | 1989 |